Prof. Melinda Fitzgerald and A/Prof. Nina Tirnitz-Parker.
Two Curtin Health Innovation Research Institute (CHIRI) researchers received a total of more than $2.24 million in funding from the latest round of National Health and Medical Research Council (NHMRC) grants.
Professor Melinda (Lindy) Fitzgerald (CHIRI/Perron Institute for Neurological and Translational Sciences) received $1,245,138 as the chief investigator of a research project looking to define the unifying mechanisms of oxidative damage to oligodendrocyte DNA in neurotrauma, neurodegenerative and demyelinating disease.
As the chief investigator of a research project targeting the TWEAK/Fn14 signalling pathway as a novel therapeutic strategy to prevent chronic liver disease progression, Associate Professor Nina Tirnitz-Parker (School of Pharmacy and Biomedical Sciences), received $997,485.
“We are thrilled with the news of a funding boost from the NHMRC and congratulate Lindy, Nina and their teams on their success,” CHIRI Director Professor John Mamo said.
“With neurodegenerative diseases and cancer being part of CHIRI’s research focus, the funding will help our institute progress important health research and hopefully find new ways to prevent, diagnose and treat some debilitating disorders and diseases that commonly occur with older age.”
This latest funding success follows CHIRI’s Dr Virginie Lam (School of Public Health) being awarded a NHMRC Early Career Fellowship earlier in the year.
NHMRC administers funding for health and medical research on behalf of the Australian Government, and invites researchers in Australia to apply for funding through schemes ranging from scholarships to research programs.
Curtin is involved in projects awarded a total of more than $10 million in the latest funding round.
